1. Home
  2. KRYS vs KTB Comparison

KRYS vs KTB Comparison

Compare KRYS & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • KTB
  • Stock Information
  • Founded
  • KRYS 2015
  • KTB 2018
  • Country
  • KRYS United States
  • KTB United States
  • Employees
  • KRYS N/A
  • KTB N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • KTB Apparel
  • Sector
  • KRYS Health Care
  • KTB Consumer Discretionary
  • Exchange
  • KRYS Nasdaq
  • KTB Nasdaq
  • Market Cap
  • KRYS 4.3B
  • KTB 3.6B
  • IPO Year
  • KRYS 2017
  • KTB N/A
  • Fundamental
  • Price
  • KRYS $150.49
  • KTB $77.39
  • Analyst Decision
  • KRYS Strong Buy
  • KTB Strong Buy
  • Analyst Count
  • KRYS 10
  • KTB 6
  • Target Price
  • KRYS $204.90
  • KTB $89.67
  • AVG Volume (30 Days)
  • KRYS 422.6K
  • KTB 935.6K
  • Earning Date
  • KRYS 08-04-2025
  • KTB 08-07-2025
  • Dividend Yield
  • KRYS N/A
  • KTB 2.68%
  • EPS Growth
  • KRYS 36.22
  • KTB 5.71
  • EPS
  • KRYS 4.91
  • KTB 4.47
  • Revenue
  • KRYS $359,205,000.00
  • KTB $2,650,638,000.00
  • Revenue This Year
  • KRYS $34.33
  • KTB $20.34
  • Revenue Next Year
  • KRYS $47.84
  • KTB $11.09
  • P/E Ratio
  • KRYS $30.77
  • KTB $17.33
  • Revenue Growth
  • KRYS 116.08
  • KTB 3.44
  • 52 Week Low
  • KRYS $122.80
  • KTB $50.00
  • 52 Week High
  • KRYS $207.84
  • KTB $96.80
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 56.41
  • KTB 73.54
  • Support Level
  • KRYS $142.51
  • KTB $70.75
  • Resistance Level
  • KRYS $147.58
  • KTB $73.53
  • Average True Range (ATR)
  • KRYS 4.78
  • KTB 2.33
  • MACD
  • KRYS 0.39
  • KTB 1.33
  • Stochastic Oscillator
  • KRYS 92.81
  • KTB 99.05

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: